Abstract

Background Previous studies demonstrated a regulatory role of interleukin 1 (IL-1) in inflammatory cartilage damage and bone destruction in human tumour necrosis factor transgenic (hTNFtg) mice, an animal model for rheumatoid arthritis. Moreover, blocking of IL-6 has been shown to reduce local bone erosions in this model. Therefore the authors wanted to investigate the effect of a combined depletion of IL-1 and IL-6 on the development and severity of inflammatory, erosive arthritis. Methods The authors first crossed IL-1α and s deficient (IL-1 −/− ) mice with IL-6 −/− mice to generate IL-1 −/− IL-6 −/− double knockout mice. The authors next intercrossed these animals with arthritogenic hTNFtg mice to receive IL-1 −/− IL-6 −/− hTNFtg mice. The authors weekly assessed clinical signs of arthritis in hTNFtg, IL-1 −/− hTNFtg mice, IL-6 −/− hTNFtg mice and IL-1 −/− IL-6 −/− hTNFtg mice starting from week 4 after birth until week 16. The authors stained decalcified paw sections from all four genotypes with H&E to determine the amount of inflammatory synovial pannus formation, with tartrate-resistant acid phosphatase (TRAP) to evaluate the number of synovial osteoclasts and the occurrence of subchondral bone erosions, with toluidine-blue to assess articular cartilage damage. Quantitative analysis of histopathological changes were performed using the Osteomeasure Software System. Results The authors found a significant reduction in the clinical signs of arthritis, indicated by an increase of paw swelling and a decrease in grip strength, in IL-1 −/− IL-6 −/− hTNFtg mice when compared to their hTNFtg littermates. In line with these findings the authors observed a significant decrease in synovial inflammation in IL-1 −/− IL-6 −/− hTNFtg mice when compared to hTNFtg animals. Moreover, the number of synovial TRAP+ osteoclasts was markedly diminished in IL-1 −/− IL-6 −/− hTNFtg mice and reduced osteoclast formation was accompanied by significantly less subchondral bone erosions. Additionally, the authors found a conserved articular cartilage structure showing almost no cartilage degradation in IL-1 −/− IL-6 −/− hTNFtg mice compared to their hTNFtg littermates. In IL-1 −/− IL-6 −/− hTNFtg mice clinical, as well as, histological signs of disease, including joint inflammation, bone destruction and cartilage damage were also significantly diminished when compared to IL-6 −/− hTNFtg mice. However, by comparing IL-1 −/− IL-6 −/− hTNFtg mice with IL-1 −/− hTNFtg mice the authors found a similar reduction on synovial inflammation, as well as subchondral bone erosions and articular cartilage destruction. Conclusion The phenotype of IL-1 −/− IL-6 −/− hTNFtg mice does not differ from IL-1 −/− hTNFtg animals indicating no synergistic effects when IL-1 and IL-6 is simultaneously blocked in TNF mediated arthritis.

Highlights

  • Acute isolated neurological syndromes, such as optic neuropathy or transverse myelopathy, may cause diagnostic problems since they can be the first presentations in a number of demyelinating disorders including multiple sclerosis (MS) and collagen diseases

  • tumor necrosis factor (TNF) therapy and demyelinating event: A report indicates that adverse events such as the demyelinating lesion in the brain, optic neuritis, and neuropathy occurred after treatment with anti-TNF alpha therapy in collagen disease, and TNF antagonizing therapy showed worsening in a clinical trial with MS

  • Believing on the similarities of normal joints in humans and monkeys, we have employed a model of collagen-induced arthritis in Macaca fascicularis in an attempt to evaluate the histological alterations caused by such condition in the extracellular matrix of the articular cartilage

Read more

Summary

Introduction

Acute isolated neurological syndromes, such as optic neuropathy or transverse myelopathy, may cause diagnostic problems since they can be the first presentations in a number of demyelinating disorders including multiple sclerosis (MS) and collagen diseases. Acute Serum Amyloid A (A-SAA) is an acute phase protein strongly expressed in rheumatoid arthritis (RA) synovial tissue (ST) critically involved in regulating cell migration and angiogenesis These processes are dependent on downstream interactions between extracellular matrix and cytoskeletal components. Conclusions: These results indicate that Egr-1 contributes to IL-1mediated down-regulation of PPARg expression in OA chondrocytes and suggest that this pathway could be a potential target for pharmacologic intervention in the treatment of OA and possibly other arthritic diseases. Immune cell-derived microparticles (MPs) are present at increased amounts in synovial fluid of rheumatoid arthritis (RA) patients [1] and can activate disease-relevant signalling pathways in RA synovial fibroblasts (SF) [2,3].

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call